Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS hedge funds down 1.06% to mid December, up 2.64% year to date

Wednesday, December 18, 2013
Opalesque Industry Update - HFRU's figures show UCITS compliant Hedge funds posted declines, with the HFRU Hedge Fund Composite Index declining -1.06% through mid-December.

HFRU Equity Hedge Index posted a decline of -1.43% through mid-December, with positive contributions from European equities offset by declines in exposures to Emerging Markets, with concentration in Brazil and China.

HFRU Event Driven Index posted a decline of -0.26% through mid-December, with mixed performance from European Equity Special Situations and Merger Arbitrage managers, while Emerging Markets exposure and credit strategies detracted from performance.

HFRU Macro Index posted a decline of -1.19% through mid-December, with declines led by Systematic CTA, Commodity – Metals managers and Emerging Markets exposures.

HFRU Relative Value Arbitrage Index posted a decline of -0.56% through mid-December, with gains in Fixed Income, Asset-Backed and Volatility strategies offset by declines in Global Multi-Strategy and Real Estate exposure.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its